ライフサイエンスコーパス: obstructive sleep apnea

1 d subjective measurements of the severity of obstructive sleep apnea.

2 nths for the treatment of moderate-to-severe obstructive sleep apnea.

3 diagnostic testing in patients suspected of obstructive sleep apnea.

4 s esophagus subjects scored at high risk for obstructive sleep apnea.

5 ovascular and cognitive consequences seen in obstructive sleep apnea.

6 ambulatory models of care for patients with obstructive sleep apnea.

7 ere associated with scoring at high risk for obstructive sleep apnea.

8 rument identifying subjects at high risk for obstructive sleep apnea.

9 ved risk outcomes associated with asthma and obstructive sleep apnea.

10 y of symptoms and signs for the diagnosis of obstructive sleep apnea.

11 isms attributed to a presymptomatic stage of obstructive sleep apnea.

12 me of sleepy patients with mild and moderate obstructive sleep apnea.

13 neck circumference (NC) and with severity of obstructive sleep apnea.

14 n undergoing adenoidectomy for chronic OM or obstructive sleep apnea.

15 ertension and primary aldosteronism and with obstructive sleep apnea.

16 patients with resistant hypertension, as is obstructive sleep apnea.

17 IF-2a should minimize motoneuronal injury in obstructive sleep apnea.

18 p studies in the evaluation of children with obstructive sleep apnea.

19 g of the pathophysiology of both central and obstructive sleep apnea.

20 omparable to that experienced by adults with obstructive sleep apnea.

21 tive injury, and residual hypersomnolence in obstructive sleep apnea.

22 to prevent oxidation-mediated morbidities in obstructive sleep apnea.

23 LTB4 and LTC4/D4/E4 emerged in children with obstructive sleep apnea.

24 that are associated with increased risk for obstructive sleep apnea.

25 teinosis and the implications of obesity and obstructive sleep apnea.

26 t interrupts breathing, a condition known as obstructive sleep apnea.

27 ationale for a new pharmacologic therapy for obstructive sleep apnea.

28 latively well-controlled type 2 diabetes and obstructive sleep apnea.

29 icular emphasis on children with more severe obstructive sleep apnea.

30 or socioeconomic factors and the presence of obstructive sleep apnea.

31 ence of diabetes mellitus, hypertension, and obstructive sleep apnea.

32 tory of diabetes mellitus, hypertension, and obstructive sleep apnea.

33 eeSurfer revealed increased gray matter with obstructive sleep apnea.

34 nasal flow monitor for 1 night to assess for obstructive sleep apnea.

35 ies to unveil its potential for reduction of obstructive sleep apneas.

36 t), body mass index >/=25kg/m(2) (+1 point), obstructive sleep apnea (+1 point), gastroesophageal ref

37 ehypertension, 15 of 18 (83.3%); symptoms of obstructive sleep apnea, 20 of 22 (90.9%); diabetes, 15

38 l cohort, 1666 (33.6%) screened positive for obstructive sleep apnea, 281 (6.5%) for moderate to seve

39 ), hypertension (2.94 vs 2.80, P = .75), and obstructive sleep apnea (3.29 vs 2.83, P = .50).

40 ion in facility revenue, 48 cases of cure of obstructive sleep apnea, 44 cases of remission of type 2

41 The percentage of children with obstructive sleep apnea (8.2% of caffeine group versus 1

42 Obstructive sleep apnea, a syndrome leading to recurrent

43 Community and referral-based prevalence of obstructive sleep apnea; accuracy of symptoms and signs

44 en made in defining the relationship between obstructive sleep apnea and cardiovascular disease.

45 hanistic and empirical bases for considering obstructive sleep apnea and central sleep apnea associat

46 a under 3 years of age and those with severe obstructive sleep apnea and comorbidities are not candid

47 causes during this period in people without obstructive sleep apnea and in the general population.

48 y driving, and the common sleep disorders of obstructive sleep apnea and insomnia.

49 ht and poor bone density; high prevalence of obstructive sleep apnea and its implications; prevalence

50 eruse headache, temporomandibular disorders, obstructive sleep apnea and obesity.

51 gardless of caffeine status, are at risk for obstructive sleep apnea and periodic limb movements in l

52 N), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing,

53 death from cardiac causes among people with obstructive sleep apnea and the following: the rates amo

54 gus patients have an increased likelihood of obstructive sleep apnea and to determine whether nocturn

55 Patients with obstructive sleep apnea and/or obesity have high atrial

56 Patients with obstructive sleep apnea and/or obesity have less freedom

57 e I diabetes, juvenile rheumatoid arthritis, obstructive sleep apnea, and after anthracycline exposur

58 icularly in children with moderate to severe obstructive sleep apnea, and also that even snoring alon

59 estyle, smoking, obesity, diabetes mellitus, obstructive sleep apnea, and elevated blood pressure pre

60 pertension, diabetes mellitus, inflammation, obstructive sleep apnea, and others.

61 81 patients with obesity, moderate-to-severe obstructive sleep apnea, and serum levels of C-reactive

62 ssive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift-work sleep disorder.

63 ion during sleep that is not attributable to obstructive sleep apnea; and (4) effectiveness of an act

64 s those associated with myocardial infarcts, obstructive sleep apneas, apneas of prematurity, Rett sy

65 s have opposite hemodynamic effects: whereas obstructive sleep apnea appears to have an adverse effec

66 he perioperative management of patients with obstructive sleep apnea are a major problem for the anes

67 Most children with obstructive sleep apnea are able to sustain stable breat

68 neas during sleep in patients suffering from obstructive sleep apnea are not well understood.

69 Treatment options for infant obstructive sleep apnea are predicated on the underlying

70 idelines for the diagnosis and management of obstructive sleep apnea are reviewed, as are recent guid

71 discuss the relationship between obesity and obstructive sleep apnea as they relate to the growing at

72 causes occurred in 46 percent of people with obstructive sleep apnea, as compared with 21 percent of

73 Among patients with obstructive sleep apnea, both CPAP and MADs were associa

74 management of more symptomatic patients with obstructive sleep apnea, but its effectiveness has not b

75 ccurs after surgery even in patients without obstructive sleep apnea, but patients with obstructive s

76 On the other hand, obstructive sleep apnea can develop as the result of a v

77 and treatment of hypertension, diabetes, and obstructive sleep apnea can reduce atrial fibrillation e

78 RATIONALE: Obstructive sleep apnea causes intermittent hypoxemia, h

79 ett's esophagus and scoring at high risk for obstructive sleep apnea compared with colonoscopy patien

80 s esophagus subjects scored at high risk for obstructive sleep apnea, compared with 42% (n = 26) of E

81 In adults with obesity and obstructive sleep apnea, CPAP combined with a weight-los

82 exacerbates hypertension, diabetes mellitus, obstructive sleep apnea, dyslipidemia, and many other di

83 s diabetes mellitus, chronic kidney disease, obstructive sleep apnea, etc.

84 This issue provides a clinical overview of Obstructive Sleep Apnea focusing on prevention, diagnosi

85 Obstructive sleep apnea has a high prevalence and is cha

86 Obstructive sleep apnea has been associated with increas

87 People with obstructive sleep apnea have a peak in sudden death from

88 e prehypertension, increased pulse pressure, obstructive sleep apnea, high-level physical training, d

89 patient-level factors that included obesity, obstructive sleep apnea, higher comorbidity, and use of

90 cators of obstruction sites in patients with obstructive sleep apnea hypopnea syndrome (OSAHS).

91 inflammatory disease, diabetes mellitus, or obstructive sleep apnea (ie, lone AF) undergoing ablatio

92 clinical recommendations on the diagnosis of obstructive sleep apnea in adults.

93 ve become a useful tool in the evaluation of obstructive sleep apnea in children with certain categor

94 pressure therapy is frequently used to treat obstructive sleep apnea in children.

95 It is anticipated that severe obstructive sleep apnea in humans destroys catecholamine

96 hypoxia (CIH), an animal model for studying obstructive sleep apnea in humans, depresses the afferen

97 sleep and is a cause of hypoventilation and obstructive sleep apnea in humans.

98 Obstructive sleep apnea in infants has a distinctive pat

99 Obstructive sleep apnea in infants has been associated w

100 Initial studies addressing the presence of obstructive sleep apnea in patients undergoing upper end

101 nto the neck in association with less severe obstructive sleep apnea in women than in men with heart

102 ht fluid shift from the legs and severity of obstructive sleep apnea in women than in men with heart

103 Obstructive sleep apnea is a common disease, responsible

104 Obstructive sleep apnea is a common disorder associated

105 Obstructive sleep apnea is a diagnosis that ophthalmolog

106 Obstructive sleep apnea is a risk factor for dyslipidemi

107 Obstructive sleep apnea is a state-dependent disease.

108 Obstructive sleep apnea is associated with AF, but it is

109 Obstructive sleep apnea is associated with an increased

110 ervational studies in men have reported that obstructive sleep apnea is associated with an increased

111 Obstructive sleep apnea is associated with considerable

112 Obstructive sleep apnea is associated with higher levels

113 Obstructive sleep apnea is associated with hypertension,

114 Epidemiological research indicates that obstructive sleep apnea is associated with increases in

115 Obstructive sleep apnea is associated with neural injury

116 A growing population of patients with obstructive sleep apnea is being referred for outpatient

117 Pediatric obstructive sleep apnea is discussed.

118 Obstructive sleep apnea is highly prevalent and associat

119 Because the prevalence of obstructive sleep apnea is lower in women than in men wi

120 Obstructive sleep apnea is primarily characterized by hy

121 Although obstructive sleep apnea is strongly associated with obes

122 nical examination of patients with suspected obstructive sleep apnea is useful for selecting patients

123 Despite the high prevalence of obstructive sleep apnea, it was not associated with the

124 importance of genetic factors in influencing obstructive sleep apnea, its genetic basis is still larg

125 Obstructive sleep apnea leads to chronic intermittent hy

126 n 26 are unlikely to have moderate or severe obstructive sleep apnea (LR, 0.07; 95% CI, 0.03-0.19 at

127 Prior studies suggest that obstructive sleep apnea may be associated with gastroeso

128 t obstructive sleep apnea, but patients with obstructive sleep apnea may have a worsening of their di

129 er a presumptive or sleep study diagnosis of obstructive sleep apnea must be made within the context

130 is uncertainty about the effects of treating obstructive sleep apnea on glycemic control in patients

131 Respondents who screened positive for obstructive sleep apnea or any sleep disorder had an inc

132 h secondary causes of hypertension including obstructive sleep apnea or primary aldosteronism.

133 oid and tonsillar tissues from children with obstructive sleep apnea or recurrent throat infections w

134 with ventilatory control disorders, such as obstructive sleep apnea, or respiratory insufficiency af

135 tal health and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and advers

136 Obstructive sleep apnea (OSA) affects 8-10% of the popul

137 mechanism underlying the association between obstructive sleep apnea (OSA) and Alzheimer's disease is

138 provide an update on the connection between obstructive sleep apnea (OSA) and cardiovascular disease

139 The relationship between obstructive sleep apnea (OSA) and cardiovascular events

140 tudies report a positive association between obstructive sleep apnea (OSA) and glaucoma; larger, retr

141 Obstructive sleep apnea (OSA) and nocturnal hypoxemia ar

142 blems in defining the diagnosis of pediatric obstructive sleep apnea (OSA) and propose a novel approa

143 Risk factors for obstructive sleep apnea (OSA) and the development of sub

144 els for surgical patients who have suspected obstructive sleep apnea (OSA) at risk for postoperative

145 Treatment is needed for obstructive sleep apnea (OSA) because untreated OSA can

146 Surgical success for obstructive sleep apnea (OSA) depends on identifying sit

147 Patients with obstructive sleep apnea (OSA) exhibit hippocampal damage

148 Obstructive sleep apnea (OSA) has been associated with i

149 ssible association between periodontitis and obstructive sleep apnea (OSA) has been suggested.

150 l clarification of the obstructive nature of obstructive sleep apnea (OSA) in 1965, much has been lea

151 linical recommendations on the management of obstructive sleep apnea (OSA) in adults.

152 An adverse role for obstructive sleep apnea (OSA) in cancer epidemiology and

153 Obstructive sleep apnea (OSA) in children is associated

154 data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10

155 study sought to identify whether obesity and obstructive sleep apnea (OSA) independently predict inci

156 Mild obstructive sleep apnea (OSA) is a highly prevalent diso

157 Obstructive sleep apnea (OSA) is a known risk factor for

158 Obstructive sleep apnea (OSA) is a low-grade inflammator

159 Obstructive sleep apnea (OSA) is a risk factor for cardi

160 Obstructive sleep apnea (OSA) is a risk factor for cardi

161 Obstructive sleep apnea (OSA) is a risk factor for type

162 Obstructive sleep apnea (OSA) is a sleep disorder charac

163 Obstructive sleep apnea (OSA) is a worldwide disease who

164 Obstructive sleep apnea (OSA) is also common in patients

165 Obstructive sleep apnea (OSA) is an underdiagnosed condi

166 Obstructive sleep apnea (OSA) is associated with atrial

167 Obstructive sleep apnea (OSA) is associated with cardiov

168 Obstructive sleep apnea (OSA) is associated with hyperte

169 Although obstructive sleep apnea (OSA) is associated with impaire

170 In adults, obstructive sleep apnea (OSA) is associated with metabol

171 Obstructive sleep apnea (OSA) is associated with oxidati

172 RATIONALE: Obstructive sleep apnea (OSA) is associated with several

173 Obstructive sleep apnea (OSA) is characterized by chroni

174 Obstructive sleep apnea (OSA) is characterized by recurr

175 Obstructive sleep apnea (OSA) is characterized by recurr

176 Obstructive sleep apnea (OSA) is characterized by repeti

177 Obstructive sleep apnea (OSA) is common in patients with

178 Obstructive sleep apnea (OSA) is common in people with h

179 Unrecognized obstructive sleep apnea (OSA) is highly prevalent in obe

180 Obstructive sleep apnea (OSA) is more common among patie

181 Obstructive sleep apnea (OSA) is strongly related to obe

182 Obstructive sleep apnea (OSA) is the most common medical

183 oratory polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA) is unclear.

184 Pediatric obstructive sleep apnea (OSA) leads to multiple end-orga

185 It is unknown whether obstructive sleep apnea (OSA) may be a risk factor for i

186 Despite emerging evidence that obstructive sleep apnea (OSA) may cause metabolic distur

187 The authors tested the hypothesis that obstructive sleep apnea (OSA) signs/symptoms are associa

188 The effect of obstructive sleep apnea (OSA) syndrome in the peripapill

189 ibrillation (AF) recurrence in patients with obstructive sleep apnea (OSA) undergoing pulmonary vein

190 to compare outcomes of patients treated for obstructive sleep apnea (OSA) versus patients with untre

191 Previous studies in obstructive sleep apnea (OSA) were limited by study coho

192 We recruited subjects with severe obstructive sleep apnea (OSA) who were well treated and

193 id phenotypes that have emerged in pediatric obstructive sleep apnea (OSA), address new concepts in o

194 hildren are at increased risk for developing obstructive sleep apnea (OSA), and both of these conditi

195 P) is considered the treatment of choice for obstructive sleep apnea (OSA), and studies have shown th

196 Childhood asthma and obstructive sleep apnea (OSA), both disorders of airway

197 Sleep abnormalities, including obstructive sleep apnea (OSA), have been associated with

198 atients with resistant hypertension (RH) and obstructive sleep apnea (OSA), the blood pressure respon

199 ationship between floppy eyelid syndrome and obstructive sleep apnea (OSA), the diagnostic criteria o

200 retinal vascular caliber and the severity of obstructive sleep apnea (OSA).

201 Body habitus is a major determinant of obstructive sleep apnea (OSA).

202 ty of the tongue is unknown in patients with obstructive sleep apnea (OSA).

203 by routine imaging methods in patients with obstructive sleep apnea (OSA).

204 ased prevalence of glaucoma in patients with obstructive sleep apnea (OSA).

205 f sudden cardiac death (SCD) associated with obstructive sleep apnea (OSA).

206 of patients with resistant hypertension have obstructive sleep apnea (OSA).

207 ay represent a critical pathology underlying obstructive sleep apnea (OSA).

208 ice (MAD) therapy are commonly used to treat obstructive sleep apnea (OSA).

209 line treatment for patients with symptomatic obstructive sleep apnea (OSA).

210 ypertension is prevalent among patients with obstructive sleep apnea (OSA).

211 (b) Obstructive sleep apnea (OSA).

212 genesis of vascular diseases associated with obstructive sleep apnea (OSA).

213 myocardial infarction (MI) in patients with obstructive sleep apnea (OSA).

214 adverse health outcomes are associated with obstructive sleep apnea (OSA).

215 s positive airway pressure for patients with obstructive sleep apnea (OSA).

216 n human subjects with high and low risks for obstructive sleep apnea (OSA).

217 tment of choice in patients with symptomatic obstructive sleep apnea (OSA).

218 ascular events, is linked to the severity of obstructive sleep apnea (OSA).

219 herapy is the most common treatment used for obstructive sleep apnea (OSA).

220 decades ago, we evaluated ten patients with obstructive sleep apnea (OSA).

221 Obstructive sleep apnea(OSA) is one of the most common s

222 xia/reoxygenation patterns simulating severe obstructive sleep apnea oxygenation, highlighting the po

223 ificantly less improvement in ACT scores was obstructive sleep apnea (P = 0.016).

224 s compared with 21 percent of people without obstructive sleep apnea (P=0.01), 16 percent of the gene

225 (ArTH) is one of several traits involved in obstructive sleep apnea pathogenesis and may be a therap

226 stoperative discharge criteria, care for the obstructive sleep apnea patient, and the choice of anest

227 onses have been found in the upper airway of obstructive sleep apnea patients, but no long-term study

228 Obstructive sleep apnea predicted incident heart failure

229 ients with suspected or sleep test confirmed obstructive sleep apnea present a formidible challenge t

230 nome-level significant findings reported for obstructive sleep apnea-related physiologic traits in an

231 tal disorder and due to a medical condition, obstructive sleep apnea, restless legs syndrome, idiopat

232 It is anticipated that obstructive sleep apnea results in endoplasmic reticulum

233 ling oxygenation patterns of moderate-severe obstructive sleep apnea, results in lasting hypersomnole

234 relationship between Barrett's esophagus and obstructive sleep apnea risk.

235 The need for obstructive sleep apnea screening in Barrett's esophagus

236 n gray matter characteristics and markers of obstructive sleep apnea severity (hypoxemia, respiratory

237 To investigate whether markers of obstructive sleep apnea severity are associated with gra

238 ts for definitive testing, the likelihood of obstructive sleep apnea should be established in the cli

239 ndition, associated with body mass index and obstructive sleep apnea, should be suspected in any obes

240 idence to recommend the routine treatment of obstructive sleep apnea specifically for the prevention

241 ecific and general quality of life measures, obstructive sleep apnea symptoms, adherence to using con

242 Many patients with obstructive sleep apnea syndrome (OSA) living near sea l

243 that overweight is modestly associated with obstructive sleep apnea syndrome (OSAS) among young chil

244 Obstructive sleep apnea syndrome (OSAS) and nonalcoholic

245 ronic intermittent hypoxia (CIH) occurs with obstructive sleep apnea syndrome (OSAS) and provokes sys

246 The prevalence of obstructive sleep apnea syndrome (OSAS) in patients with

247 Obstructive sleep apnea syndrome (OSAS) is associated wi

248 Obstructive sleep apnea syndrome (OSAS) leads to neuroco

249 e are also a few studies suggesting that the obstructive sleep apnea syndrome (OSAS) may compromise o

250 aims to investigate the correlation between obstructive sleep apnea syndrome (OSAS) risk with period

251 e (CPAP) in asthma patients with concomitant obstructive sleep apnea syndrome (OSAS) seems to have a

252 l disease has been reported in patients with obstructive sleep apnea syndrome (OSAS), and these two c

253 ucture, hippocampus-dependent cognition, and obstructive sleep apnea syndrome (OSAS).

254 therapy plays a role in treating snoring and obstructive sleep apnea syndrome (OSAS).

255 s during tidal breathing in 10 children with obstructive sleep apnea syndrome (OSAS; age, 4.3 +/- 2.3

256 lished previously regarding the evolution of obstructive sleep apnea syndrome and persistence of abno

257 We have observed a significant prevalence of obstructive sleep apnea syndrome in patients in waiting

258 watchful waiting, surgical treatment for the obstructive sleep apnea syndrome in school-age children

259 Obstructive sleep apnea syndrome involves abnormal upper

260 Obstructive sleep apnea syndrome is a highly prevalent d

261 Previous studies have suggested that the obstructive sleep apnea syndrome may be an important ris

262 d to determine the independent effect of the obstructive sleep apnea syndrome on the composite outcom

263 , atrial fibrillation, and hypertension, the obstructive sleep apnea syndrome retained a statisticall

264 The obstructive sleep apnea syndrome significantly increases

265 464 children, 5 to 9 years of age, with the obstructive sleep apnea syndrome to early adenotonsillec

266 Prevalence of obstructive sleep apnea syndrome was 38% before the LT,

267 In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with str

268 The diagnosis of the obstructive sleep apnea syndrome was based on an apnea-h

269 We hypothesized that, in children with the obstructive sleep apnea syndrome without prolonged oxyhe

270 ncluded obesity (body mass index [BMI] >35), obstructive sleep apnea syndrome, or other causes of res

271 ated to patient (Mallampati score III or IV, obstructive sleep apnea syndrome, reduced mobility of ce

272 y is commonly performed in children with the obstructive sleep apnea syndrome, yet its usefulness in

273 essure in asthmatics with moderate to severe obstructive sleep apnea syndrome.

274 enrolled patients, 697 (68 percent) had the obstructive sleep apnea syndrome.

275 Obesity and obstructive sleep apnea tend to coexist and are associat

276 s were more likely to score at high risk for obstructive sleep apnea than patients without nocturnal

277 nferiority study involving 155 patients with obstructive sleep apnea that was treated at primary care

278 he following: the rates among people without obstructive sleep apnea, the rates in the general popula

279 For people with obstructive sleep apnea, the relative risk of sudden dea

280 ader on the most recent developments linking obstructive sleep apnea to cardiovascular disease.

281 of this study was to assess the relation of obstructive sleep apnea to incident coronary heart disea

282 Among patients with obstructive sleep apnea, treatment under a primary care

283 Children with obstructive sleep apnea under 3 years of age and those w

284 Primary care management of obstructive sleep apnea vs usual care in a specialist sl

285 Prevalence of severe obstructive sleep apnea was 51% (95% confidence interval

286 After adjustment for multiple risk factors, obstructive sleep apnea was a significant predictor of i

287 The severity of obstructive sleep apnea was assessed by the apnea-hypopn

288 Obstructive sleep apnea was diagnosed when the AHI was 1

289 ul observation for identifying patients with obstructive sleep apnea was nocturnal choking or gasping

290 Rates of scoring at high risk for obstructive sleep apnea were compared.

291 Subjects at high risk for obstructive sleep apnea were excluded through the Berlin

292 an inactive control) on BP in patients with obstructive sleep apnea were selected by consensus.

293 uch as smokers, diabetics, and subjects with obstructive sleep apnea, where their prolonged contact w

294 or choking is the most reliable indicator of obstructive sleep apnea, whereas snoring is not very spe

295 The presence of obstructive sleep apnea whether diagnosed by a surrogate

296 r-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accept

297 ll trials provide evidence that treatment of obstructive sleep apnea with continuous positive airway

298 ardiovascular risk factors, the treatment of obstructive sleep apnea with CPAP, but not nocturnal sup

299 Patients were screened for obstructive sleep apnea with the use of the Berlin quest

300 type 2 diabetes and no previous diagnosis of obstructive sleep apnea, with a glycated hemoglobin leve